Barclays Maintains Overweight on SLM, Lowers Price Target to $27

Benzinga Newsdesk www.benzinga.com Negative 90.3%

Neg 90.3% Neu 0% Pos 0%

Barclays analyst Terry Ma maintains SLM (NASDAQ:SLM) with a Overweight and lowers the price target from $35 to $27.

Comments

No comments yet. Be the first!